|
|
Volumn 11, Issue 7, 2005, Pages 590-593
|
|
COX-2 inhibitors: little or no GI protection, increased risk of cardiovascular events, high cost, and other class-less effects.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN SYNTHASE INHIBITOR;
CARDIOVASCULAR DISEASE;
CHEMICALLY INDUCED DISORDER;
DIGESTIVE SYSTEM;
DRUG COST;
DRUG EFFECT;
ECONOMICS;
EDITORIAL;
HUMAN;
RISK ASSESSMENT;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CARDIOVASCULAR DISEASES;
CYCLOOXYGENASE INHIBITORS;
DIGESTIVE SYSTEM;
DRUG COSTS;
HUMANS;
RISK ASSESSMENT;
|
|
EID: 27744554822
PISSN: 10834087
EISSN: None
Source Type: Journal
DOI: 10.18553/jmcp.2005.11.7.590 Document Type: Editorial |
|
Times cited : (1)
|
|
References (0)
|
